Hepatitis Forums
Fatty Liver Disease Main Forums => Nonalcoholic Steatohepatitis (NASH) => Topic started by: iana5252 on May 07, 2015, 09:30:29 am
-
The American Liver Foundation (ALF) predicts obesity-related fatty liver diseases such as nonalcoholic steatohepatitis (NASH) could affect as many as half of all Americans by 2030. ALF estimates that NASH already affects up to 30 percent of the U.S. population. NASH has no cure; doctors can only recommend patients lose weight.
New drugs could help address the advanced fibrosis and cirrhosis caused by HBV and NASH. The treatments may also be able to prevent liver cancer. If successful, the drugs could bring in as much as $10 billion annually once they’re approved.
http://www.hepmag.com/articles/hbv_nash_treatment_research_2831_26440.shtml